The polymerase chain reaction (PCR) can be used to detect small quantities of hepatitis B virus (HBV) DNA, generally by testing for one or two gene sequences, in liver and serum from patients without detectable markers of HBV. It is sometimes necessary to distinguish the detection of HBV DNA from false-positive results due to contamination by carry-over of previously amplified PCR products. Occasional use of """"""""multi-target"""""""" PCR using primer sets for portions of the three HBV genes, C, S, and X, simultaneously can verify the lack of contamination by carry-over and enhance the accuracy of PCR.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CP005693-01
Application #
3853587
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Division of Cancer Epidemiology and Genetics
Department
Type
DUNS #
City
State
Country
United States
Zip Code